Search PubMed⌕ Search

Biomedical subjects

P Irwin

Publications and source records attributed to P Irwin.

At least 37 records · Page 2Linked to original sources

Expression of mitogen-activated protein kinase pathways during postnatal development of rat heart.

The loss of ability to proliferate (terminal differentiation) and reduction in capability to resist ischemia are key phenomena observed during postnatal development of the heart. Mitogen-activated protein kinases (MAPKs) mediate signaling pathways for cell proliferation/differentiation and stress responses such as ischemia. In this study, the expression of these kinases and their associated kinases were investigated in rat heart ventricle. Extracts of 1-, 10-, 20-, 50-, and 365-day-old rat heart ventricles were probed with specific antibodies and their immunoreactivities were quantified by densitometry. Most of the mitogenic protein kinases including Raf1, RafB, Mek1, Erk2, and Rsk1 were significantly down-regulated, whereas the stress signaling kinases, such as Mlk3, Mekkl, Sekl, Mkk3, and Mapkapk2 were up-regulated in expression during postnatal development. Most MAP kinases including Erk1, JNKs, p38 Hog, as well as Rsk2, however, did not exhibit postnatal changes in expression. The proto-oncogene-encoded kinases Mos and Cot/Tpl 2 were up-regulated up to two- and four-fold, respectively, during development. Pakl, which may be involved in the regulation of cytoskeleton as well as in stress signaling, was downregulated with age, but the Pak2 isoform increased only after 50 days. All of these proteins, except RafB, were also detected in the isolated adult ventricular myocytes at comparable levels to those found in adult ventricle. Tissue distribution studies revealed that most of the protein kinases that were up-regulated during heart development tended to be preferentially expressed in heart, whereas the downregulated protein kinases were generally expressed in heart at relatively lesser amounts than in most of other tissues.

Amino Acid Sequence↗

The structure of the exopolysaccharide of Pseudomonas fluorescens strain H13.

An acidic exopolysaccharide was isolated from P. fluorescens strain H13. The structure of the polysaccharide repeating unit was determined using chemical methods and 1D and 2D NMR techniques. The repeating unit was characterized as a trisaccharide composed of D-glucose, 2-acetamido-2-deoxy-D-glucose and 4-O-acetyl-2-acetamido-2-deoxy-D-mannuronic acid.

Acetylglucosamine↗

Near-infrared spectroscopy and spectral mapping of Jupiter and the Galilean satellites: results from Galileo's initial orbit.

The Near Infrared Mapping Spectrometer performed spectral studies of Jupiter and the Galilean satellites during the June 1996 perijove pass of the Galileo spacecraft. Spectra for a 5-micrometer hot spot on Jupiter are consistent with the absence of a significant water cloud above 8 bars and with a depletion of water compared to that predicted for solar composition, corroborating results from the Galileo probe. Great Red Spot (GRS) spectral images show that parts of this feature extend upward to 240 millibars, although considerable altitude-dependent structure is found within it. A ring of dense clouds surrounds the GRS and is lower than it by 3 to 7 kilometers. Spectra of Callisto and Ganymede reveal a feature at 4. 25 micrometers, attributed to the presence of hydrated minerals or possibly carbon dioxide on their surfaces. Spectra of Europa's high latitudes imply that fine-grained water frost overlies larger grains. Several active volcanic regions were found on Io, with temperatures of 420 to 620 kelvin and projected areas of 5 to 70 square kilometers.

Ammonia↗

Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease.

SDZ ENA 713 (ENA 713) is an acetylcholinesterase inhibitor being developed as a potential treatment for Alzheimer's disease (AD). A prior Phase II safety and efficacy study used an upper dose limit of 6 mg/day ENA 713. The present study was designed to assess the safety and tolerability of higher doses of ENA 713 in probable AD patients. Fifty AD patients (22M; 28F, mean age 68 yrs, range 45-90) were assigned to a fixed, nine-week dose escalation schedule in which they were randomized to receive up to 12 mg/day of ENA 713 bid (n=20) or tid (n=20), or placebo (n=10) followed by a one-week washout. Mg/day dose escalation for the bid and tid ENA 713 groups was identical, beginning with 2 mg/day on Days 1 to 3 and escalating to 12 mg/day in Weeks 8 and 9. Doses through 12 mg/day were well tolerated. Most adverse events were mild to moderate in severity and of limited duration, most commonly headache, nausea, dizziness, and diarrhea. Three of forty patients on ENA 713 discontinued, all due to adverse events. Two experienced nausea and vomiting; the third experienced an unrelated mild atrial fibrillation.

Aged↗

Developing and using a patient satisfaction survey: a case study.

Patient satisfaction is an important component of quality management in student health services. Satisfaction can influence if, where, and when a student seeks care, follows instructions, and continues a relationship with a specific provider. This case study describes the rationale for and process used in designing a system to measure patient satisfaction for the university health services at The Pennsylvania State University. In addition to collecting information about the health center from its clients, the authors obtained valuable information about survey development, administration, and data management. Their experience will guide future efforts to improve both the quality of services offered and the methods the health center uses to measure clients' satisfaction with those services.

Adolescent↗

Impaired bladder perfusion in interstitial cystitis: a study of blood supply using laser Doppler flowmetry.

Laser doppler flowmetry was used to study bladder blood flow in 16 patients with interstitial cystitis and in 18 control subjects. All studies were performed at cystoscopy under general anesthesia. Interstitial cystitis patients conformed to the diagnostic criteria of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Blood flow measurements were made at four specific sites in the bladder at a capacity of 100 ml. and at full capacity. The mean maximum capacity under anesthesia was 828 cc for the control group and 562 cc for the IC group. Blood flow at low capacity was similar in the two groups. When the bladder was filled to capacity, blood flow increased by a mean of 9.05 LDF units in the control group but only by 0.06 LDF units in the IC group (p = 0.007). Vault perfusion increased considerably more in the control group compared to the IC group (p = 0.002). The mean ratio of vault to trigonal perfusion was similar in both groups and was not affected by the overall blood flow changes which accompanied distension. Although the mean bladder capacity under anesthesia was greater in the control group, covariant analysis showed that the significant differences in perfusion between the two groups occurred independently of changes in capacity. It is concluded that bladder perfusion at capacity is significantly impaired in interstitial cystitis.

Cystitis↗

The perception of empathy in alcoholism counselors.

Alcoholic inpatients evaluated the level of empathy demonstrated by a purported alcoholism counselor. Forty-two detoxified subjects viewed a 15-min videotape of a simulated alcoholism counseling session. Subjects had been randomly assigned to one of two groups: Group 1 was told that the counselor they were about to see was a recovering alcoholic whose empathy they were to evaluate. The subjects in Group 2 were given the same instructions; however, the information concerning the counselor's drinking history was omitted. A form of the Barrett-Lennard Relationship Inventory (BLRI) was administered immediately after the viewing. No statistical differences between group means on the empathy subscale of the BLRI were found. This finding does not support the contention that a history of drinking and rehabilitation enhances the perception of counselor empathy among alcoholics.

Adult↗

Greater brain response of left-handers to drugs.

Among subjects participating in 14 placebo-controlled drug cross-over studies, left-handers showed a greater drug-related change in their electroencephalograms (EEGs) than did right-handers. Response differences between left- and right-handers were not hemisphere-specific. Further, the magnitude of EEG changes correlated with handedness scores. A greater effect of centrally active substances in left-handers may, in part, explain the high incidence of left-handers among those with certain brain-related pathologies and the evolution of right-hander predominance in the general population.

Adult↗

Determination of the central effects of the asthma prophylactic ketotifen, the bronchodilator theophylline, and both in combination: an application of quantitative electroencephalography to the study of drug interactions.

Ketotifen (Zaditen) is a new, orally active benzocycloheptathiophene derivative for use in the prophylaxis of asthma. Besides possessing anti-allergic properties, it also has H1-receptor mediated antihistaminic activity. Drugs which block H1-receptors are known to have some sedative properties. On the other hand the bronchodilator theophylline is a CNS stimulant. We investigated whether these side-effects could be reduced by concomitant administration. In a balanced-sequence crossover study, 12 healthy males received placebo, 1 mg ketotifen + 300 mg theophylline, 1 mg ketotifen + 600 mg theophylline, and each drug separately at 1-week intervals. Quantified electroencephalograms, cardiovascular and behavioral measurements, symptom reports, and blood drug assays were used to assess the drug interaction. Results showed EEG and behavioral effects with both ketotifen and theophylline alone which were less evident with the drugs in combination. Blood drug levels were not altered by combined drug administration. These findings suggest a mutual attenuation of the CNS effects of ketotifen and theophylline at therapeutic doses and encourage their combined use in asthma therapy. The combined effect may be optimized by modifying formulations or timing. The applicability of quantitative EEG to such problems is well demonstrated.

Adult↗

Assessment of the quality of life in long-term survivors after definitive radiotherapy.

An interview questionnaire was developed to assess quality of life both in objective and subjective terms in cancer patients. Standardized measures were employed and allowed for comparison with a national baseline. Three hundred thirty-nine patients who were alive without evidence of disease 3 or more years following initial treatment were interviewed. There was no difference in terms of educational level, marital status, or satisfaction with local government, family, job, friends, community, health, recreation, or activities when compared to the age-adjusted national baseline. The patients were more satisfied with region, self, and life as a whole. There was no evidence of a diminished quality of life in these patients.

Adolescent↗

Familiarization session and placebo control in EEG studies of drug effects.

The need for a familiarization session and for a placebo session for each subject in pharmaco-EEG studies was examined. The data from 18 crossover studies of 22 substances at 33 doses in 112 subjects was used: 371 drug sessions, 195 placebo sessions and 53 familiarization sessions. The left occipital to vertex signal was quantified using power spectral density analyses. EEG changes under different conditions were compared using the spectral difference index. Less EEG change from baseline was found after placebo in the first session than after placebo in later sessions. Drug effects were defined by comparisons to placebo effects in the same subjects (related samples analyses) and to placebo effects in other subjects in the data base (independent samples analyses). Decisions using the two analyses were in accord for 27 substance doses: 20 were found active, 7 inactive. For one substance, the related samples analysis indicated drug activity, while the independent samples analysis did not (just below criterion). For five other substances, the related samples analyses did not distinguish drug and placebo sessions, while the independent samples analyses showed lesser EEG changes after drug than after placebo. First-session findings support the need for a familiarization session in pharmaco-EEG studies. Placebo findings indicate that past placebo session data are adequate for deciding whether a drug has CNS activity, without the necessity of a placebo session for each subject.

Adult↗

Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.

The effects of a single oral dose of 6-azamianserin (2 mg) were compared to those of mianserin (6 mg), flurazepam (10 mg), and placebo in 11 healthy male volunteers, in a crossover design. Quantitative EEG, heart rate, blood pressure, task performance, and subjective state were measured. EEG and behavioral measures distinguished the substances from placebo. 6-Azamianserin was similar to mianserin in type and duration of effects. In a separate study in 12 volunteers, 0.5 and 1.0 mg of the (+) and (-) enantiomers of 6-azamianserin elicited dose-related EEG and behavioral effects, distinguishable from placebo. These effects were similar to those elicited by racemic 6-azamianserin and mianserin. Clinical trials of 6-azamianserin in depressed patients, particularly the elderly and those with cardiovascular disease, are warranted. Dosages selected should be one-third those of mianserin. The stereospecific properties of the enantiomers in preclinical tests predict that any clinical 'antidepressant' activity will reside in the (+) isomer only, while the pharmaco-EEG trials predict that both enantiomers will be clinically 'antidepressant'. Clinical testing of the isomers, particularly the (-) isomer, is indicated as a test of the predictive value of pharmacologic and pharmaco-EEG models of clinical antidepressant activity.

Adult↗

Spectral difference index: a single EEG measure of drug effect.

A single EEG measure of drug effect, the spectral difference index (SDI), was compared to other quantitative measures for its sensitivity to drugs from 7 different clinical classes. The other measures included relative power in 2 c/sec bands from 0 to 17 c/sec, and in 4c/sec bands from 18 to 29 c/sec; relative power and average frequency in the bands 1-5, 6-13 and 14-30 c/sec; and the Hjorth time domain descriptors. The SDI was the most sensitive EEG discriminator between drug and placebo sessions. It is presently used in our pharmaco-EEG studies to test whether a drug has significantly altered the EEG. Its use has been extended to interhemispheric studies.

Adult↗

Central nervous system effects of aspirin.

The EEG effects of aspirin at single doses of 0.65 and 1.95 gm were studied in normal adult men. Compared to placebo, 1.95 gm affected the quantitative EEG, symptom self reports, and cognitive functions. The effects of 0.65 gm. were similar in direction and pattern, but failed measurable significance. The EEG profile of aspirin is distinct from that of other psychoactive substances. Its interaction with sedative substances should be considered in routine clinical use.

Adult↗

Blood levels and the quantitative EEG response to CNS-active drugs: retrospective observations.

Quantitative EEG measures provide reliable, non-invasive indices of CNS effects of drugs in man. In pharmaco-EEG studies of CNS-active substances, we found that EEG changes correlated with blood drug levels within individuals over time, and showed the correlation to be replicable. Across individuals at single times, however, correlations were not evident. In seeking relationships across subjects, techniques which adjust for EEG baseline differences between subjects are under investigation.

Adult↗

Neuroendocrine measures in psychiatric patients: course and outcome with ECT.

Measures of neuroendocrine function--plasma cortisol and its response to dexamethasone, and plasma thyroid-stimulating hormone (TSH) and its response to thyrotropin-releasing hormone (TRH)--were employed in 50 hospitalized male veteran psychiatric patients with diagnoses of unipolar or bipolar melancholia, secondary depression, or schizophrenia. Of 20 cases of unipolar melancholia, 17 (85%) exhibited hypercortisolism; 14 (70%) failed to suppress plasma cortisol after dexamethasone; and 4 (31%) of 13 tested had an abnormal TSH response to intravenous TRH. Two patients with secondary depression also exhibited hypercortisolism; no other patients evinced abnormal neuroendocrine test results. These measures were repeated in 14 unipolar depressed patients after a course of electroconvulsive therapy (ECT). Improvement in psychopathology was directly related to normalization of measures of hypothalamic-pituitary-adrenal (HPA) function. The TSH response to TRH was not systematically altered. After a followup period of 1 to 9 months, there was a good correlation between the measures of HPA function and the clinical outcome. These findings encourage further study of HPA function measures as outcome criteria for depressed patients receiving ECT.

Adult↗